Motorists find it tough to negotiate Nanthoor junction

[email protected] ( Raghava M, The Hindu)
March 28, 2011

nanthoor

Mangalore, March 28: Shivaram Kulashekar had his “heart in his mouth” when he lost control over his autorickshaw which accidentally entered a ditch near Nanthoor Circle. “Fortunately nothing untoward happened. There were three passengers in my vehicle,” he said.

This ditch between the junction of the national highway and Bikarnakatte Road is among the many hurdles that motorists have to keep an eye while passing the Nanthoor junction.

“This is the busiest junction that is also difficult for motorists to negotiate,” said autorickshaw driver Babu Kulashekar.

It is at this junction that vehicles coming from the Karnataka Polytechnic side join those from the Pumpwell, Mallikatta and Bikarnakatte side. Many heavy vehicles, including those carrying petroleum and chemicals, proceeding towards Udupi, Bangalore and Kerala have to cross this junction. Buses proceeding towards Neermarga, Pilikula, Kuntikana, Bajpe and Moodbidre also pass through the junction.

The problem in negotiating the junction has been more so for motorists going to the city from Bikarnakatte.

“It is difficult to spot the vehicles coming from the polytechnic side or from the Pumpwell side. This has resulted in many accidents,” said Deepak Bikarnakatte.

“The saving grace is the (Bikarnakatte) road-widening work. It has slowed down the speed of vehicles and has brought the number of accidents down,” he said.

The traffic signal light at this junction has not been of any use. “It only creates traffic jams. It stopped functioning six years ago,” said Raj who hails from the area. The constable posted at the junction finds it hard to control traffic.

“There will be traffic jams on the Mallikatta side and the Bikarnakatte side during peak hours,” said Joe D'Costa.

The traffic would be heavy around 9 a.m. and 6 p.m., he said.

Motorists said the authorities were yet to act on a proposal for a flyover at the junction.

“It becomes all the more necessary as a new bus stand is coming up near Pumpwell,” said Shivaram Kulashekar. A proposal to build a flyover here was recently shelved by the National Highways Authority of India.

There appears to be no immediate solution to the problems of motorists.

Deputy Commissioner of Police (Crime and Traffic) Mutturaya said work on the Nantoor junction could be taken up only after completion of the Bikarnakatte road-widening work.

An assistant sub-inspector had been posted to regulate traffic at Nantoor junction during peak hours, he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 2,2020

Bengaluru, Ju 2 As many as 19 deaths and 1,502 new COVID-19 cases were reported in Karnataka till 5 pm on Thursday, as per information provided by the State Health Department.

The total number of COVID-19 cases in the state now stands at 18,016, including 9,406 active cases.

While 8,334 patients have been discharged after treatment, 272 people have succumbed to the virus.

India's COVID-19 tally breached the 6 lakh cases mark with 19,148 new coronavirus cases being reported in the last 24 hours, informed the Union Ministry of Health and Family Welfare on Thursday.

The total cases now stand at 6,04,641 of which there are 2,26,947 active cases while 3,59,860 patients have been cured/discharged/migrated. 434 deaths have been reported in the last 24 hours taking the number of COVID-19 deaths in the country to 17,834.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 29,2020

Newsroom, Apr 29: Abdul Rahman Al Sudais, the imam of the Grand Mosque in Makkah has hinted that Muslims will be allowed to perform prayers again at the holiest mosque after a few days. 

Al Sudais, who is also the president of the General Presidency for the Affairs of the Two Holy Mosques, predicted this while answering a question from a reporter about the possibility of having worshippers gather again at the mosque.

He said that soon people will be allowed to return to the mosque for prayers and for circumambulation around the holy Kaaba.

The authorities care about people more than anything else, he said. "All Muslims should pray to Allah to help us through this pandemic. People must be careful and take necessary precautions to protect themselves and others," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.